Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 289
Selected: 0
NCT IDTitle
NCT04225572Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)
NCT01181258Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
NCT00176826T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
NCT04555811FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL
NCT00888316Iron Overload in Patients Undergoing Donor Stem Cell Transplant
NCT02171104MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
NCT02948062Early Diagnosis Of Childhood Cerebral ALD
NCT05665543Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
NCT02156674Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
NCT03213964Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
NCT01566682A Multi-Center Trial of the ProLung Test™
NCT00305682Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant
NCT05308316Sugars in Cigarettes
NCT00258362Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
NCT00625729Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
NCT00775931Allogeneic Transplantation For Severe Osteopetrosis
NCT00176852Stem Cell Transplant for Hemoglobinopathy
NCT01885897IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT01033552Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
NCT03421678Ethnic/Racial Differences in Metabolism and DNA Adduct Formation
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT00365287Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
NCT03789721Adrenoleukodystrophy National Registry Study
NCT00617929Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
NCT03365661QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
NCT01593618Empowering Cancer Survivors Through Information Technology
NCT01343368Preservation of Ovarian Function After Hematopoietic Cell Transplant
NCT01685411Busulfan and Cyclophosphamide Followed By ALLO BMT
NCT00869323Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
NCT03946423BAriaTric Surgery After Breast Cancer Treatment (BATS)
NCT00176878Stem Cell Transplant for Bone Marrow Failure Syndromes
NCT00176891Stem Cell Transplant w/Laronidase for Hurler
NCT01105650Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
NCT00357565Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
NCT02845414Study of CD133KDEL Toxin in the Treatment for Solid Tumors
NCT05700630Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
NCT01572636Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
NCT00392782Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
NCT01581970Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
NCT01593670Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
NCT00376805Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
NCT01850888MIBG for Refractory Neuroblastoma and Pheochromocytoma
NCT00290628Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
NCT06213298Effect of Kava on Anxiety and Stress in Cancer Survivors
NCT03297463Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
NCT03678493A Study of FMT in Patients With AML Allo HSCT in Recipients
NCT04426669A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
NCT00903630Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00331422Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00309842Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases